FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/11/2024
Voltar para busca
Dado oficial do USPTO
RBGALSTAR
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
RBGALSTAR
ST13
US500000079351185Classe
1, 5, 42
Pedido
79351185
Registro
7341611
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
32
Atualização mais recente
02/11/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42
Data de depósito
15/07/2022
Data de registro
02/04/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
02/04/2024
Última transação
02/04/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
16
Localização do titular
CN
Examinador
LAVACHE, LINDA M
Unidade examinadora
L60
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Suzhou Ribo Life Science Co., Ltd.
Representantes
Hamre Schumann Muller & Larson, P.C.
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Industrial chemicalsglucosides; carbonic hydrates; polymer resinsunprocessed; artificial resinsunprocessed; chemical preparations in the nature of ion-exchange resins; enzymes for industrial purposes; enzymes for the food industry; biochemical catalysts; industrial chemicals; chemical preparations for scientific purposesother than for medical or veterinary use
Classe 5
Medicines for humans for the treatment of cardiovascular diseasesmetabolic diseasesliver diseasesgenetic disorders; pharmaceutical preparations for the treatment of cardiovascular diseasesmetabolic diseasesliver diseasesgenetic disorders; chemico-pharmaceutical preparations for the treatment of cardiovascular diseasesmetabolic diseasesliver diseasesgenetic disorders; drugs for medical purposespharmaceutical preparations for the treatment of cardiovascular diseasesmetabolic diseasesliver diseasesgenetic disorders; biological preparations for medical purposes for the treatment of cardiovascular diseasesmetabolic diseasesliver diseasesgenetic disorders; chemical preparations for pharmaceutical purposes for the treatment of cardiovascular diseasesmetabolic diseasesliver diseasesgenetic disorders; chemical preparations for medical purposes for the treatment of cardiovascular diseasesmetabolic diseasesliver diseasesgenetic disorders; crude drugs being pharmaceutical preparations for the treatment of cardiovascular diseasesmetabolic diseasesliver diseasesgenetic disorders; pharmaceuticals for the treatment of cancer; pharmaceuticals for the treatment of infectious diseases; diagnostic preparations for medical purposes; dietetic substances adapted for medical usedietary supplements and dietetic foods adapted for medical use; depuratives for the body; pharmaceutical preparations for the treatment of hypercholesteremia; pesticides; pharmaceutical preparations for the treatment of hyperlipidemia; pharmaceutical preparations for treating diabetes; pharmaceutical agents affecting metabolism; anticoagulants; medicines for veterinary purposes for the treatment of gastrointestinal diseases and condition; cardiovascular pharmaceuticals; pharmaceutical preparations for ocular or intraocular surgery; dressingsmedical; composite materials for dental purposes; diapers for pets
Classe 42
Technological research in the field of pharmaceutical manufacturing processes and pharmaceutical studies; development of pharmaceutical preparations and medicines; pharmaceutical product evaluation; pharmaceutical research and development services; research in the field of pharmaceuticals; quality control for others; scientific research; chemical research and analysis; development and testing of chemical production methods; biochemistry research services; medical and scientific researchconducting clinical trials for others; medical research; testing of pharmaceuticals; industrial design
Publicações
Histórico de despachos e eventos da marca no USPTO.
32 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
16/10/2024
FIMP
FINAL DISPOSITION PROCESSED
16/10/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/07/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/04/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
02/04/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
25/03/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/03/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
06/03/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
16/01/2024
PUBO
PUBLISHED FOR OPPOSITION
16/01/2024
GPNX
NOTIFICATION PROCESSED BY IB
13/01/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
27/12/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
27/12/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
27/12/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/12/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
12/12/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/12/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
12/12/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/12/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/12/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/12/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/12/2023
RFNP
REFUSAL PROCESSED BY IB
10/07/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
15/06/2023
RFRR
REFUSAL PROCESSED BY MPU
14/06/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/05/2023
CNRT
NON-FINAL ACTION WRITTEN
04/05/2023
DOCK
ASSIGNED TO EXAMINER
02/05/2023
MAFR
APPLICATION FILING RECEIPT MAILED
04/10/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
30/09/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
29/09/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace RBGALSTAR ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.